
Depracort 750mg Tablet XR
Marketer
AGM Biotec
Salt Composition
Divalproex (750mg)
Overview Depracort 750mg Tablet XR
Epileptic seizures and migraine prophylaxis are key indications for the extended-release formulation of Cortidep 750mg tablets. This medication can also be employed, on occasion, as an adjunct in bipolar disorder management. Dosage and frequency are determined individually by your physician to optimize symptom control, potentially in conjunction with other therapies. Administer this medication at the same time daily, with or without food, for consistent efficacy; therapeutic effects typically manifest within a couple of weeks. Continuous use, as prescribed, is crucial to prevent seizure recurrence and condition exacerbation; abrupt cessation is strongly discouraged. Common, generally mild, adverse effects encompass headache, visual blurring, nausea, vomiting, vertigo, fatigue, instability, easy bruising, and hypothermia. While continued use is advised, report persistent or bothersome side effects to your doctor immediately; skin rashes necessitate prompt medical attention. Prolonged use may contribute to osteoporosis, increasing fracture risk, and, rarely, may induce suicidal ideation or behavior; report any depressive mood changes promptly. Prior to commencing treatment, disclose any history of cardiac, renal, or hepatic impairment, urinary difficulties, depression, or suicidal tendencies. Inform your doctor of all concomitant medications to avoid potential drug interactions. Consult your physician before altering medication usage during pregnancy. Alcohol consumption should be minimized to mitigate the risk of intensified side effects and increased seizure susceptibility. Regular blood monitoring is often necessary to optimize dosing, both pre- and post-treatment initiation.
Uses of Depracort 750mg Tablet XR
Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prevention
Major Benefits of Depracort 750mg Tablet XR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Depracort 750mg XR tablets. These tablets should be swallowed whole; avoid chewing, crushing, or breaking them. While Depracort 750mg XR tablets can be administered with or without food, consistency is key – take them at the same time each day.
Common Side effects of Depracort 750mg Tablet XR:
- Decreased body temperature
- Dizziness
- Sleepiness
- Tremors
- Paresthesia (tingling or pricking sensation)
- Anemia (low number of red blood cells)
- Decreased sodium level in blood
- Liver injury
- Gastrointestinal disturbance
- Hypersensitivity
- Deafness
- Urinary incontinence
- Increase in body weight
- Pain during periods
How to use Depracort 750mg Tablet XR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Depracort 750mg Extended-Release Tablets can be consumed with or without food; however, consistent daily timing is recommended.
How Depracort 750mg Tablet XR works:
Extended-release Depracort 750mg tablets are used to treat epilepsy. They work by reducing hyperactivity within the brain's neuronal network, thus controlling seizures.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Depracort 750mg extended-release tablets and alcohol may induce significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Extended-release Depracort 750mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Depracort 750mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.
DrivingUNSAFE
Extended-release Depracort 750mg tablets can induce adverse reactions that might impair driving capabilities.
KidneySAFE IF PRESCRIBED
Extended-release Depracort 750mg tablets are considered safe for use in individuals with kidney impairment. No alteration in Depracort 750mg XR dosage is necessary.
LiverUNSAFE
Extended-release Depracort 750mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Physician consultation is advised.
What if you forget to take Depracort 750mg Tablet XR :
Should you forget a Depracort 750mg XR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Depracort 750mg Tablet XR
| Label | Value |
|---|---|
| Chemical Type | Derivatives of Aliphatic Carboxylic Acids |
| Developing Habits | No. |
| Treatment Category | Central Nervous System (CNS) Neurology |
| Actions | Antiepileptic drugs that modulate sodium channels |
